You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Deferoxamine

Showing 26 - 50 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Malignant Solid Tumor Trial in Duarte (procedure, radiation, drug)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Lymphoma
  • Positron Emission Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Different Risk Factors on Growth Parameters of Thalassemic

Not yet recruiting
  • Thalassemia Major
  • serum ferritin and AST
  • (no location specified)
Mar 29, 2022

Sickle Cell Disease Trial in Amsterdam (Deferasirox 360 MG)

Recruiting
  • Sickle Cell Disease
  • Deferasirox 360 MG
  • Amsterdam, Meibergdreef 9, Netherlands
    Amsterdan UMC location AMC
May 23, 2022

Huntington Disease Trial (NestaCell®)

Not yet recruiting
  • Huntington Disease
  • NestaCell®
  • (no location specified)
Oct 18, 2023

Heart Defects, Congenital Trial in Austin (Dexrazoxane)

Recruiting
  • Heart Defects, Congenital
  • Austin, Texas
    Dell Children's Medical Center of Central Texas
Aug 2, 2021

Transfusion-dependent Thalassemia, Non-transfusion-dependent Thalassemia Trial in Worldwide (Deferasirox dispersable tablet

Completed
Has Results
  • Transfusion-dependent Thalassemia
  • Non-transfusion-dependent Thalassemia
  • Deferasirox dispersable tablet (DT)
  • Deferasirox film coated tablet (FCT)
  • Alexandria, Egypt
  • +16 more
Sep 6, 2021

Multiple Myeloma Trial in New York (drug, device, other)

Completed
Has Results
  • Multiple Myeloma
  • New York, New York
    Memorial Slaon-Kettering Cancer Center
Jul 9, 2021

Diabetes Type 2, Diastolic Dysfunction, Cardiac MRI Trial in Copenhagen Ø (Liraglutide, Placebo)

Completed
  • Diabetes Mellitus Type 2
  • +3 more
  • Copenhagen Ø, Denmark
    The department of cardiology, Rigshospitalet Denmark
Jan 13, 2021

Intracerebral Hemorrhage Trial in Boston (Deferoxamine Mesylate)

Completed
  • Intracerebral Hemorrhage
  • Deferoxamine Mesylate
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 11, 2018

Choroidal Thickness in Beta-thalassemia Patients

Completed
  • Beta-Thalassemia
  • EDI-OCT
  • Patras, Achaea, Greece
    Department of Ophthalmology, General University Hospital of Patr
Jun 24, 2020

Chronic Iron Overload Trial in Worldwide (Deferiprone, Deferasirox)

Completed
Has Results
  • Chronic Iron Overload
  • Lushnjë, Albania
  • +21 more
Apr 8, 2021

Erythrocyte Transfusion, Beta-Thalassemia Trial in Worldwide (Luspatercept, Placebo)

Completed
Has Results
  • Erythrocyte Transfusion
  • Beta-Thalassemia
  • Los Angeles, California
  • +72 more
Jan 21, 2022

Intracranial Aneurysm, Subarachnoid Hemorrhage Trial in Nijmegen, Groningen (Deferoxamine, )

Unknown status
  • Intracranial Aneurysm
  • Subarachnoid Hemorrhage
  • Deferoxamine
  • placebo
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Sep 26, 2017

Cardiovascular Diseases, Heart Diseases, Beta-Thalassemia Trial in United States (Deferoxamine, Deferiprone (L1))

Terminated
Has Results
  • Cardiovascular Diseases
  • +2 more
  • Deferoxamine
  • Deferiprone (L1)
  • Los Angeles, California
  • +5 more
Feb 1, 2018

High Risk MDS or AML Patients Trial in Philadelphia (Exjade® (deferasirox, ICL670))

Completed
  • High Risk MDS or AML Patients
  • Exjade® (deferasirox, ICL670)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 7, 2020

MDS Trial in Belgium

Unknown status
  • Myelodysplastic Syndromes
    • Bonheiden, Antwerpen, Belgium
    • +20 more
    Aug 9, 2019

    Beta-thalassemia, MDS, Fanconi Syndrome Trial in United States (Deferasirox)

    Completed
    • Beta-thalassemia
    • +4 more
    • Oakland, California
    • +5 more
    Aug 17, 2017

    Anemia, Sickle Cell Trial in United States (ICL670, deferoxamine)

    Completed
    • Anemia, Sickle Cell
    • ICL670, deferoxamine
    • Mobile, Alabama
    • +33 more
    Aug 18, 2017

    Evaluate Cognitive and Brain Function of ß-thalassemia Patients.

    Unknown status
    • Thalassemia
    • Brain Function (Measured by ERP Level)
      • Afula, Israel
        Haemek Medical Center
      Oct 30, 2019

      Thalassemia Major With Severe Transfusional Iron Overload Trial in Chicago, Philadelphia (Deferasirox and deferiprone)

      Completed
      Has Results
      • Thalassemia Major With Severe Transfusional Iron Overload
      • Deferasirox and deferiprone
      • Chicago, Illinois
      • +1 more
      Feb 13, 2019

      Sickle Cell Disease, Hemoglobin SC Trial in Houston (Busulfan, Campath 1H, Cyclophosphamide and MESNA)

      Terminated
      Has Results
      • Sickle Cell Disease
      • Hemoglobin SC
      • Houston, Texas
      • +1 more
      Jul 16, 2020

      Iron Mediated Vascular Disease in Sickle Cell Anemia Patients

      Completed
      • Sickle Cell Disease
        • Los Angeles, California
          Children's Hospital Los Angeles
        Jan 9, 2019

        Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone)

        Unknown status
        • Iron Overload
        • +2 more
        • Oakland, California
        • +12 more
        Jan 10, 2019

        Postmenopausal Osteoporosis Trial in Suzhou (Deferasirox and calcium-vitamin D3, Calcium-vitamin D3)

        Unknown status
        • Postmenopausal Osteoporosis
        • Deferasirox and calcium-vitamin D3
        • Calcium-vitamin D3
        • Suzhou, Jiangsu, China
          Second Affiliated Hospital of Soochow University
        May 13, 2018

        Thalassemia Trial in Karachi (Standard Chelation, Amlodipine)

        Completed
        • Thalassemia
        • Karachi, Sindh, Pakistan
          Aga Khan University Hospital
        Jun 28, 2017